Zusammenfassung
Die Überlegenheit minimal-invasiver Operationsmethoden gegenüber der offenen Chirurgie in Bezug auf verschiedene Parameter des Kurzzeitoutcomes mit adäquaten onkologischen Langzeitergebnissen wurde bereits bei vielen Tumorentitäten in hochqualitativen Studien belegt. Die immer weiter verbreitete Roboter-Chirurgie bietet in der minimal-invasiven onkologischen Viszeralchirurgie einige zusätzliche Vorteile, wie die hochauflösende dreidimensionale, stabile Sicht, vollständige Bewegungsfreiheit im Situs, Filterung des natürlichen Tremors und bessere Ergonomie. Dieser Artikel evaluiert nach Kriterien der evidenzbasierten Medizin, ob sich diese postulierten Vorteile in einer Verbesserung der kurzfristigen perioperativen und langfristigen onkologischen Ergebnisse gegenüber der herkömmlichen minimal-invasiven Chirurgie in der onkologischen Viszeralchirurgie (Rektum, Kolon, Magen, Ösophagus, Pankreas, Leber) niederschlagen. Mit Ausnahme der kolorektalen Chirurgie liegen in der onkologischen Viszeralchirurgie derzeit keine randomisiert-kontrollierten Studien (RCTs) zum Vergleich der robotischen mit der laparoskopischen Chirurgie bei viszeralonkologischen Krankheitsbildern vor. Es zeigt sich eine deutliche Diskrepanz zwischen der exponentiell zunehmenden Verbreitung des Operationsroboters und der noch unzureichenden Datenlage. Weitere RCTs sind insbesondere vor dem Hintergrund des großen technologischen Entwicklungspotenzials der robotischen Chirurgie dringend geboten.
Abstract
The superiority of minimally invasive operative methods compared to open surgery with respect to various parameters of short-term outcome with adequate oncological long-term results has already been confirmed for many tumor entities in high-quality studies. The continuously expanding robotic surgery offers certain additional benefits in minimally invasive oncological visceral surgery, such as a high-resolution stable 3‑dimensional view, optimal freedom of movement in situ, elimination of natural tremor and better ergonomics. This article evaluates whether these postulated advantages are reflected in an improvement of the short-term perioperative and long-term oncological results compared to conventional minimally invasive surgery in oncological visceral surgery (rectum, colon, stomach, esophagus, pancreas, liver) according to the criteria of evidence-based medicine. With the exception of colorectal surgery, there are currently no randomized controlled studies comparing robotic to laparoscopic surgery in oncological visceral surgery. There is still a clear imbalance between the exponentially expanding application of robotic surgery and the existing lack of high-quality evidence. Further randomized controlled clinical trials urgently need to be performed especially considering the great technological development potential of robotic surgery.
Literatur
Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, Smith AM, Heath RM, Brown JM, M.C.t. group (2005) Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet 365:1718–1726
Jayne DG, Guillou PJ, Thorpe H, Quirke P, Copeland J, Smith AM, Heath RM, Brown JM, U.M.C.T. Group (2007) Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3‑year results of the UK MRC CLASICC Trial Group. J Clin Oncol. 25:3061–3068
Kirchberg J, Mees T, Weitz J (2016) Robotics in the operating room: out of the niche into widespread application. Chirurg 87:1025–1032
Coughlin GD, Yaxley JW, Chambers SK, Occhipinti S, Samaratunga H, Zajdlewicz L, Teloken P, Dunglison N, Williams S, Lavin MF, Gardiner RA (2018) Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study. Lancet Oncol 19:1051–1060
Jayne D, Pigazzi A, Marshall H, Croft J, Corrigan N, Copeland J, Quirke P, West N, Rautio T, Thomassen N, Tilney H, Gudgeon M, Bianchi PP, Edlin R, Hulme C, Brown J (2017) Effect of robotic-assisted vs conventional laparoscopic surgery on risk of conversion to open laparotomy among patients undergoing resection for rectal cancer: the ROLARR randomized clinical trial. JAMA 318:1569–1580
Yaxley JW, Coughlin GD, Chambers SK, Occhipinti S, Samaratunga H, Zajdlewicz L, Dunglison N, Carter R, Williams S, Payton DJ, Perry-Keene J, Lavin MF, Gardiner RA (2016) Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study. Lancet 388:1057–1066
Prete FP, Pezzolla A, Prete F, Testini M, Marzaioli R, Patriti A, Jimenez-Rodriguez RM, Gurrado A, Strippoli GFM (2018) Robotic versus laparoscopic minimally invasive surgery for rectal cancer: a systematic review and meta-analysis of randomized controlled trials. Ann Surg 267:1034–1046
Debakey Y, Zaghloul A, Farag A, Mahmoud A, Elattar I (2018) Robotic-assisted versus conventional laparoscopic approach for rectal cancer surgery, first Egyptian academic center experience, RCT. Minim Invasive Surg 2018. https://doi.org/10.1155/2018/5836562
Kim MJ, Park SC, Park JW, Chang HJ, Kim DY, Nam BH, Sohn DK, Oh JH (2018) Robot-assisted versus laparoscopic surgery for rectal cancer: a phase II open label prospective randomized controlled trial. Ann Surg 267:243–251
Ma S, Chen Y, Chen Y, Guo T, Yang X, Lu Y, Tian J, Cai H (2018) Short-term outcomes of robotic-assisted right colectomy compared with laparoscopic surgery: a systematic review and meta-analysis. Asian J Surg. https://doi.org/10.1016/j.asjsur.2018.11.002
Park JS, Choi GS, Park SY, Kim HJ, Ryuk JP (2012) Randomized clinical trial of robot-assisted versus standard laparoscopic right colectomy. Br J Surg 99:1219–1226
Park JS, Kang H, Park SY, Kim HJ, Woo IT, Park IK, Choi GS (2018) Long-term oncologic after robotic versus laparoscopic right colectomy: a prospective randomized study. Surg Endosc. https://doi.org/10.1007/s00464-018-6563-8
Chen K, Pan Y, Zhang B, Maher H, Wang XF, Cai XJ (2017) Robotic versus laparoscopic gastrectomy for gastric cancer: a systematic review and updated meta-analysis. BMC Surg 17:93
Pan JH, Zhou H, Zhao XX, Ding H, Qin L, Pan YL (2017) Long-term oncological outcomes in robotic gastrectomy versus laparoscopic gastrectomy for gastric cancer: a meta-analysis. Surg Endosc 31:4244–4251
Pan HF, Wang G, Liu J, Liu XX, Zhao K, Tang XF, Jiang ZW (2017) Robotic versus laparoscopic gastrectomy for locally advanced gastric cancer. Surg Laparosc Endosc Percutan Tech 27:428–433
Wang WJ, Li HT, Yu JP, Su L, Guo CA, Chen P, Yan L, Li K, Ma YW, Wang L, Hu W, Li YM, Liu HB (2018) Severity and incidence of complications assessed by the Clavien-Dindo classification following robotic and laparoscopic gastrectomy for advanced gastric cancer: a retrospective and propensity score-matched study. Surg Endosc. https://doi.org/10.1007/s00464-018-06624-7
Uyama I, Suda K, Nakauchi M, Kinoshita T, Noshiro H, Takiguchi S, Ehara K, Obama K, Kuwabara S, Okabe H, Terashima M (2018) Clinical advantages of robotic gastrectomy for clinical stage I/II gastric cancer: a multi-institutional prospective single-arm study. Gastric Cancer https://doi.org/10.1007/s10120-018-00906-8 (Epub ahead of print)
van der Sluis PC, Ruurda JP, van der Horst S, Verhage RJ, Besselink MG, Prins MJ, Haverkamp L, Schippers C, Rinkes IH, Joore HC, Ten FJK, Koffijberg H, Kroese CC, van Leeuwen MS, Lolkema MP, Reerink O, Schipper ME, Steenhagen E, Vleggaar FP, Voest EE, Siersema PD, van Hillegersberg R (2012) Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer, a randomized controlled trial (ROBOT trial). Trials 13:230
van der Sluis PC, van der Horst S, May AM, Schippers C, Brosens LAA, Joore HCA, Kroese CC, Haj NM, Mook S, Vleggaar FP, Borel Rinkes IHM, Ruurda JP, van Hillegersberg R (2018) Robot-assisted minimally invasive thoracolaparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer: a randomized controlled trial. Ann Surg. https://doi.org/10.1097/SLA.0000000000003031 (Epub ahead of print)
van der Sluis PC, Ruurda JP, Verhage RJ, van der Horst S, Haverkamp L, Siersema PD, Borel Rinkes IH, Ten FJK, van Hillegersberg R (2015) Oncologic long-term results of robot-assisted minimally invasive thoraco-laparoscopic esophagectomy with two-field lymphadenectomy for esophageal cancer. Ann Surg Oncol 22(3):S1350–S1356
de la Fuente SG, Weber J, Hoffe SE, Shridhar R, Karl R, Meredith KL (2013) Initial experience from a large referral center with robotic-assisted Ivor Lewis esophagogastrectomy for oncologic purposes. Surg Endosc 27:3339–3347
Cerfolio RJ, Wei B, Hawn MT, Minnich DJ (2016) Robotic esophagectomy for cancer: early results and lessons learned. Semin Thorac Cardiovasc Surg 28:160–169
Weksler B, Sharma P, Moudgill N, Chojnacki KA, Rosato EL (2012) Robot-assisted minimally invasive esophagectomy is equivalent to thoracoscopic minimally invasive esophagectomy. Dis Esophagus 25:403–409
He H, Wu Q, Wang Z, Zhang Y, Chen N, Fu J, Zhang G (2018) Short-term outcomes of robot-assisted minimally invasive esophagectomy for esophageal cancer: a propensity score matched analysis. J Cardiothorac Surg 13:52
Zhou JY, Xin C, Mou YP, Xu XW, Zhang MZ, Zhou YC, Lu C, Chen RG (2016) Robotic versus laparoscopic distal pancreatectomy: a meta-analysis of short-term outcomes. PLoS ONE 11:e151189
Guerrini GP, Lauretta A, Belluco C, Olivieri M, Forlin M, Basso S, Breda B, Bertola G, Di Benedetto F (2017) Robotic versus laparoscopic distal pancreatectomy: an up-to-date meta-analysis. BMC Surg 17:105
Strijker M, van Santvoort HC, Besselink MG, van Hillegersberg R, Borel Rinkes IH, Vriens MR, Molenaar IQ (2013) Robot-assisted pancreatic surgery: a systematic review of the literature. HPB (Oxford) 15:1–10
Zureikat AH, Moser AJ, Boone BA, Bartlett DL, Zenati M, Zeh HJ 3rd (2013) 250 robotic pancreatic resections: safety and feasibility. Ann Surg 258:554–559 (discussion 559–562)
Montalti R, Berardi G, Patriti A, Vivarelli M, Troisi RI (2015) Outcomes of robotic vs laparoscopic hepatectomy: a systematic review and meta-analysis. World J Gastroenterol 21:8441–8451
Tsilimigras DI, Moris D, Vagios S, Merath K, Pawlik TM (2018) Safety and oncologic outcomes of robotic liver resections: a systematic review. J Surg Oncol 117:1517–1530
Berber E, Akyildiz HY, Aucejo F, Gunasekaran G, Chalikonda S, Fung J (2010) Robotic versus laparoscopic resection of liver tumours. HPB (Oxford) 12:583–586
Lai EC, Tang CN (2016) Long-term survival analysis of robotic versus conventional laparoscopic hepatectomy for hepatocellular carcinoma: a comparative study. Surg Laparosc Endosc Percutan Tech 26:162–166
Troisi RI, Patriti A, Montalti R, Casciola L (2013) Robot assistance in liver surgery: a real advantage over a fully laparoscopic approach? Results of a comparative bi-institutional analysis. Int J Med Robot 9:160–166
Montalti R, Scuderi V, Patriti A, Vivarelli M, Troisi RI (2016) Robotic versus laparoscopic resections of posterosuperior segments of the liver: a propensity score-matched comparison. Surg Endosc 30:1004–1013
Kissler HJ, Bauschke A, Settmacher U (2016) First national survey on use of robotics for visceral surgery in Germany. Chirurg 87:669–675
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
J. Weitz gibt Forschungsunterstützung durch Intuitive Surgical an. J. Kirchberg gibt Forschungsunterstützung durch Intuitive Surgical an.
Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.
Rights and permissions
About this article
Cite this article
Kirchberg, J., Weitz, J. Evidenz der Roboter-Chirurgie in der onkologischen Viszeralchirurgie. Chirurg 90, 379–386 (2019). https://doi.org/10.1007/s00104-019-0812-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00104-019-0812-9
Schlüsselwörter
- Automatische Datenverarbeitung
- Künstliche Intelligenz
- Evidenzbasierte Medizin
- Kolorektale Chirurgie
- Laparoskopische Chirurgie